A candidate canine distemper virus (CDV) ISCOM vaccine has been shown to be effective in protecting harbour seals (Phoca vitulina) from phocid distemper in 1988. However, of the 35 harbour seals receiving this vaccine upon admission to a seal rehabilitation and research centre (Pieterburen, The Netherlands) in 1989, six developed mild inflammatory symptoms of the respiratory tract. Phocid distemper virus-1 (PDV-1) could be isolated from three of these animals. This indicates that the vaccine affords protection from phocid distemper, but may still allow PDV-1 infection of the respiratory tract. Contacts with non-vaccinated seals should then be prevented until no more virus is excreted. It is speculated that this PDV-1 infection of the respiratory tract in CDV-ISCOM vaccinated seals is followed by a lifelong immunity.

, , , , , , , ,
doi.org/10.1016/0264-410X(92)90390-6, hdl.handle.net/1765/3441
Vaccine
Erasmus MC: University Medical Center Rotterdam

Visser, I.K.G, Vedder, E.J, Örvell, C, Barrett, T, Osterhaus, A.D.M.E, & van de Bildt, M.W.G. (1992). Canine distemper virus ISCOMS induce protection in harbour seals (Phoca vitulina) against phocid distemper but still allow subsequent infection with phocid distemper virus-1. Vaccine, 10(7), 435–438. doi:10.1016/0264-410X(92)90390-6